Ronald Andrews

Ronald Andrews

Directeur/Membre du Conseil chez PRECIPIO, INC.

Fortune : 360 149 $ au 31/05/2026

66 ans
Health Technology
Health Services
Technology Services

Profil

Ronald Asbury Andrews was the founder of Bethesda Group Fund, founded in 2015, serving as Principal.
Current jobs include Executive Chairman at Dxcover Ltd. since 2023; Director at Oxford Immunotec Ltd. since 2015; Director at Mission Hospital Foundation; Director at Quest Diagnostics TB LLC since 2015; Independent Director at Cellmax, Inc. since 2023; Independent Director at Precipio, Inc. since 2021; Independent Director at Plus Therapeutics, Inc. starting 2026; Director at Precipio Diagnostics LLC; Trustee at Wofford College; and Member-Supervisory Board at Agendia, Inc. since 2023.
Former jobs include Chief Executive Officer-GE Molecular Diagnostics at Clarient, Inc. from 2010 to 2012; Chief Executive Officer-Clarient Business Unit at GE Healthcare, Inc. in 2012; Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc. in 2022; Chief Executive Officer & Director at Twinstrand Biosciences, Inc. from 2023 to 2024; Executive Chairman at SimBioSys, Inc. from 2022 to 2024; Independent Non-Executive Director at Oxford Immunotec Global Ltd. from 2015 to 2021; Director at Cardiac Science Corp.
from 2009 to 2010; Independent Director at Orion Health Group Ltd. and Orion Health Ltd. from 2016 to 2018; Director at Insight Genetics, Inc. from 2015 to 2019; Vice President at Immucor, Inc.; Vice President-Marketing at Roche Diagnostics Corp.; President-Genetic Sciences Division at Thermo Fisher Scientific, Inc. from 2013 to 2014; Senior Vice President-Global Marketing at Roche Molecular Systems, Inc. from 2000 to 2004; Senior Marketing Manager-Business Unit Operations at Abbott Diagnostics, Inc.; President-Medical Sciences at Life Technologies Corp.
from 2012 to 2013; Member-Governors Board at CancerLinQ LLC from 2016 to 2023; and Managing Partner at Ph Blueprint.
Education includes an undergraduate degree from Wofford College, conferred in 1981.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/04/2026 15 796 ( 0,88 % ) 360 149 $ 31/05/2026
14/05/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Ronald Andrews

SociétésPosteDébut
PRECIPIO, INC. Directeur/Membre du Conseil 01/03/2021
PLUS THERAPEUTICS, INC. Directeur/Membre du Conseil 20/03/2026
Directeur/Membre du Conseil -
Président 06/09/2023
Directeur/Membre du Conseil 14/06/2023
Directeur/Membre du Conseil 06/04/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2015
Directeur/Membre du Conseil 01/01/2015
░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Ronald Andrews

SociétésPosteFin
░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ronald Andrews

Formation de Ronald Andrews

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées29

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Mission Hospital Foundation

Health Services

Health Technology

Commercial Services

Health Technology

Technology Services

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Services

Finance

Technology Services

Ph Blueprint

Health Technology

  1. Bourse
  2. Insiders
  3. Ronald Andrews
🔇